- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 1, 2022Chambers USA Recognizes Five Robins Kaplan Practice Groups And 17 Lawyers In 2022 Guide
-
June 1, 2022Seasoned Attorney Joins Firm’s Business Litigation Group
-
May 26, 2022Shira Shapiro Named Woman of Promise By The Pearl Society
-
June 3, 202219th Annual Advanced Insurance Law
-
June 9, 2022Building Your Brand: Perspectives and Insights from a Diverse Bar
-
June 10, 2022LGBTQ Legal Services: Transgender Name Change Clinic
-
May 24, 2022Briefly: Seeking Fees and Costs While on Appeal
-
May 19, 202211th Circ. Ban On Service Awards May Inhibit Class Actions
-
May 13, 2022Trademark Applications and the Murky Waters of Subject Matter Jurisdiction
-
June 2, 2022Sandberg Stepping Down as Meta COO After 14 Years
-
June 1, 2022Markets Revert to Recent Form as Pessimism Takes Hold
-
May 27, 2022Unexpectedly Strong Retail Sales Pull Markets Back from the Brink
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
2011/2012
| Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
|---|---|---|---|---|
| 10/3/2011 | Propecia | Finasteride | Merck | Sun Pharma Global |
| 10/3/2011 | Unipen | Nafcillin Sodium | Wyeth | Acic Fine Chems |
| 10/4/2011 | Keppra XR | Levetiracetam | Ucb Inc | Anchen Pharms |
| 10/06/2011 | Lamictal | Lamotrigine | Glaxosmithkline | Unichem Labs Ltd |
| 10/06/2011 | Leustatin | Cladribine | Janssen Pharms | Onco Therapies Ltd |
| 10/06/2011 | Neurontin | Gabapentin | Pfizer Pharms | Aurobindo Pharma Ltd |
| 10/07/2011 | Retrovir | Zidovudine | Viiv Hlthcare | Hec Pharm Inc |
| 10/13/2011 | Keppra XR | Levetiracetam | Ucb Inc | Hikma Farmaceutica |
| 10/17/2011 | Keppra XR | Levetiracetam | Ucb Inc | Lupin Ltd |
| 10/17/2011 | Derma-Smoothe/FS | Fluocinolone Acetonide | Hill Dermac | Identi Pharms Inc |
| 10/17/2011 | Derma-Smoothe/FS | Fluocinolone Acetonide | Hill Dermac | Identi Pharms Inc |
| 10/17/2011 | Derma-Smoothe/FS | Fluocinolone Acetonide | Hill Dermac | Identi Pharms Inc |
| 10/18/2011 | Marcaine Hydrochloride | Bupivacaine Hydrochloride | Hospira | Sagent Strides |
| 10/18/2011 | Marcaine Hydrochloride | Bupivacaine Hydrochloride | Hospira | Sagent Strides |
| 10/18/2011 | Marcaine Hydrochloride | Bupivacaine Hydrochloride | Hospira | Sagent Strides |
| 10/18/2011 | MS Contin | Morphine Sulfate | Purdue Pharma LP | Mylan Pharms Inc |
| 10/19/2011 | Robinul | Glycopyrrolate | Shionogi Inc | Boca Pharma |
| 10/19/2011 | Zinecard | Dexrazoxane Hydrochloride | Pharmacia And Upjohn | Mylan Institutional |
| 10/21/2011 | Robaxin | Methocarbamol | Schwarz Pharma | Austarpharma Llc |
| 10/24/2011 | Zyprexa | Olanzapine | Lilly | Teva Pharms |
| 10/24/2011 | Zyprexa | Olanzapine | Lilly | Dr Reddys Labs Ltd |
| 10/24/2011 | Zyprexa | Olanzapine | Lilly | Par Pharm |
| 10/24/2011 | Zyprexa | Olanzapine | Lilly | Apotex Inc |
| 10/24/2011 | Zyprexa | Olanzapine | Lilly | Innopharma Llc |
| 10/24/2011 | Tenuate Dospan | Diethylpropion Hydrochloride | Watson Pharms | Lannett Holdings Inc |
| 10/25/2011 | Adderall | Dextroamphetamine Sulfate | Teva And Barr Pharmaceuticals | Mikart |
| 10/25/2011 | Zyprexa | Olanzapine | Lilly | Torrent Pharms Llc |
| 10/25/2011 | Loseasonique (Generic Drug) | Ethinyl Estradiol; Levonorgestrel | Teva Womens | Watson Labs |
| 10/26/2011 | Cefotetan | Cefotetan Disodium | App Pharms | West-Ward Pharm Corp |
| 10/26/2011 | Cefotetan | Cefotetan Disodium | App Pharms | West-Ward Pharm Corp |
| 10/26/2011 | Merrem | Meropenem | Astrazeneca | Acs Dobfar |
| 10/26/2011 | Loseasonique (Generic Drug) | Ethinyl Estradiol; Levonorgestrel | Teva Womens | Lupin Ltd |
| 10/27/2011 | Cellcept | Mycophenolate Mofetil | Allergan | Dr Reddys Labs Ltd |
| 10/27/2011 | Gastrocrom | Cromolyn Sodium | Azur Pharma | Pack Pharms Llc |
| 10/28/2011 | Cardizem CD | Diltiazem Hydrochloride | Valeant Intl | Sun Pharma Global |
| 10/28/2011 | Doxil | Doxorubicin Hydrochloride | Janssen Pharms | Onco Therapies Ltd |
| 10/31/2011 | Elestat | Epinastine Hydrochloride | Allergan | Apotex |
| 10/31/2011 | Elestat | Epinastine Hydrochloride | Allergan | Pharmaforce |
| 10/31/2011 | Elestat | Epinastine Hydrochloride | Allergan | Sun Pharm Inds |
| 10/31/2011 | Anaprox | Aurobindo Pharma Ltd | Allergan | Aurobindo Pharma Ltd |
| 11/03/2011 | Cyklokapron | Tranexamic Acid | Pharmacia And Upjohn | Bioniche Pharma |
| 11/04/2011 | Plendil | Felodipine | Astrazeneca | Endo Pharms |
| 11/04/2011 | Gabitril | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Sun Pharm Inds |
| 11/04/2011 | Risperdal | Risperidone | Janssen Pharms | Jubilant Organosys |
| 11/04/2011 | Cellcept | Mycophenolate Mofetil | Roche Palo | Alkem Labs Ltd |
| 11/07/2011 | XyzalL | Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | Synthon Pharms |
| 11/08/2011 | Naprosyn | Naproxen | Roche Palo | Aurobindo Pharma Usa |
| 11/09/2011 | Carboplatin | Carboplatin | Teva Parenteral / Pharmachemie | Onco Therapies Ltd |
| 11/10/2011 | Tylenol With Codein | Acetaminophen; Codeine Phosphate | Ortho-McNeil Pharma | Vintage Pharms |
| 11/10/2011 | Kadian | Morphine Sulfate | Actavis Elizabeth | Watson Labs |
| 11/16/2011 | Primaxin | Cilastatin Sodium; Imipenem | Merck | Hospira Inc |
| 11/16/2011 | Primaxin | Cilastatin Sodium; Imipenem | Merck | Hospira Inc |
| 11/16/2011 | Teveten | Eprosartan Mesylate | Abbott | Mylan Pharms Inc |
| 11/17/2011 | Epivir | Lamivudine | Viiv Hlthcare | Aurobindo Pharma Ltd |
| 11/17/2011 | Cyklokapron | Tranexamic Acid | Pharmacia And Upjohn | Versapharm Inc |
| 11/18/2011 | Buphenyl | Sodium Phenylbutyrate | Medicis | Ampolgen |
| 11/21/2011 | Arava | Leflunomide | Sanofi Aventis US | Alembic Pharms Ltd |
| 11/23/2011 | Loseasonique (Generic Drug) | Ethinyl Estradiol; Levonorgestrel | Teva Womens | Vintage Pharms |
| 11/23/2011 | Carboplatin | Carboplatin | Teva Parenteral / Pharmachemie | Onco Therapies Ltd |
| 11/25/2011 | Carbatrol | Carbamazepine | Shire | Apotex Inc |
| 11/28/2011 | Lovenox | Enoxaparin Sodium | Sanofi Aventis US | Sandoz Inc |
| 11/28/2011 | Yaz | Drospirenone; Ethinyl Estradiol | Bayer Hlthcare | Watson Labs |
| 11/28/2011 | Ultram | Tramadol Hydrochloride | Janssen Pharms | Alvogen |
| 11/28/2011 | Plendil | Felodipine | Astrazeneca | Torrent Pharms Ltd |
| 11/29/2011 | Risperdal | Risperidone | Janssen Pharms | Prinston Inc |
| 11/30/2011 | Lipitor | Atorvastatin Calcium | Pfizer | Ranbaxy Labs Ltd |
| 11/30/2011 | Solodyn | Minocycline Hydrochloride | Medicis | Lupin Ltd |
| 12/01/2011 | Ritalin LA | Methylphenidate Hydrochloride | Novartis | Actavis |
| 12/02/2011 | Epivir | Lamivudine | Viiv Hlthcare | Apotex |
| 12/06/2011 | Pamine | Methscopolamine Bromide | Nycomed US | Breckenridge Pharm |
| 12/06/2011 | Catapres | Clonidine Hydrochloride | Boehringer Ingelheim | Alembic Pharms Ltd |
| 12/06/2011 | Sanctura | Trospium Chloride | Allergan | Apotex |
| 12/07/2011 | Glucophage | Metformin Hydrochloride | Bristol Myers Squibb | Apotex |
| 12/07/2011 | Ultram | Tramadol Hydrochloride | Valeant Intl | Sun Pharma Global |
| 12/09/2011 | Dyazide | Hydrochlorothiazide; Triameterene | Glaxosmithkline | Lannett Holdings Inc |
| 12/12/2011 | Vfend | Voriconazole | Pfizer | Sandoz Inc |
| 12/13/2011 | Ritalin LA | Methylphenidate Hydrochloride | Novartis | Actavis |
| 12/13/2011 | Cytarabine | Cytarabine | Hospira | Onco Therapies Ltd |
| 12/13/2011 | Cytarabine | Cytarabine | Hospira | Onco Therapies Ltd |
| 12/13/2011 | Cytarabine | Cytarabine | Hospira | Onco Therapies Ltd |
| 12/14/2011 | Doryx | Doxycycline Hyclate | Mayne Pharma | Actavis Elizabeth |
| 12/15/2011 | Toprol XL (Lopressor) | Metoprolol Succinate | Novartis | Mylan Pharms Inc |
| 12/16/2011 | Camptosar | Irinotecan Hydrochloride | Pfizer | Jiangsu Hengrui Med |
| 12/16/2011 | Felbamate | Felbamate | Meda Pharms | Amneal Pharms |
| 12/19/2011 | Keppra XR | Levetiracetam | UCB Inc | Mylan Pharms Inc |
| 12/20/2011 | Vibramycin | Doxycyline | Pfizer | Heritage Pharms Inc |
| 12/20/2011 | Augmentin / Clavamox | Amoxicillin; Clavulante Potassium | Glaxosmithkline / Pfizer | Aurobindo Pharma Ltd |
| 12/20/2011 | Augmentin / Clavamox | Amoxicillin; Clavulante Potassium | Glaxosmithkline / Pfizer | Aurobindo Pharma Ltd |
| 12/21/2011 | Kayexalate | Sodium Polystyrene Sulfonate | Sanofi Aventis US | Cedar Pharms |
| 12/21/2011 | Unasyn | Ampicillin Sodium; Sulbactam Sodiu | Pfizer | Hospira Inc |
| 12/21/2011 | Primaxin | Cilastatin Sodium; Imipenem | Merck | Acs Dobfar |
| 12/21/2011 | Unasyn | Ampicillin Sodium; Sulbactam Sodiu | Pfizer | Hospira Inc |
| 12/21/2011 | Unasyn | Ampicillin Sodium; Sulbactam Sodiu | Pfizer | Hospira Inc |
| 12/21/2011 | Fludara | Fludarabine Phosphate | Teva Parenteral / Sandoz | Onco Therapies Ltd |
| 12/22/2011 | Clarinex | Desloratadine | Schering Plough | Perrigo R and D |
| 12/22/2011 | Generess Fe | Norethindrone; Ethinyl Estradiol | Watson Pharms | Novast Labs Ltd |
| 12/22/2011 | Ortho-Novum 7/7/7-28 | Ethinyl Estradiol; Norethindrone | Janssen Pharms | Novast Labs Ltd |
| 12/22/2011 | Ovcon-35 | Ethinyl Estradiol; Norethindrone | Warner Chilcott | Novast Labs Ltd |
| 12/22/2011 | Ortho-Novum | Ethinyl Estradiol; Norethindrone | Janssen Pharms | Novast Labs Ltd |
| 12/23/2011 | Tricor | Fenofibrate | Abbott Labs Pharm | Lupin Ltd |
| 12/23/2011 | Urso Forte | Ursodiol | Aptalis Pharma US | Watson Labs Inc |
| 12/30/2011 | Osmoprep | Sodium Phosphate, Diabasic anhydrous; Sodium Phosphate, Monobasic, Monohydrate | Salix | Novel Labs Inc |
| 12/30/2011 | Relafen | Nabumetone | Smithkline Beecham | Apotex Inc |
| 12/30/2011 | Isoptin SR | Verapamil Hydrochloride | Pfizer | Sun Pharm Inds |
GENERICally Speaking Winter 2011/2012
Related Professionals
Related Publications
First Quarter
ANDA Litigation Settlements
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
New ANDA Cases
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
ANDA Approvals
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
Generic Launches
GENERICally Speaking Hatch Waxman Bulletin
March 22, 2022
Genentech, Inc. v. Sandoz, Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
August 2, 2021
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.